August 2022

PPG Announces INNOVEL PRO PPG Technology, an Update to Its Bisphenol-Free Beverage Can Coating

PITTSBURGH, Aug. 1, 2022–PPG (NYSE: PPG) announced PPG INNOVEL® PRO, an innovative internal spray coating that does not use bisphenol-A (BPA) or bisphenol starter and provides more physically powerful application homes for infinitely recyclable aluminum beverage cans.

PPG Announces INNOVEL PRO PPG Technology, an Update to Its Bisphenol-Free Beverage Can Coating Read More »

Xponential Fitness Signs Master Franchise Agreement in Japan for CycleBar

IRVINE, Calif. , August 1, 2022: Xponential Fitness, Inc. (NYSE: XPOF), the world’s largest fitness brand franchisor, announced that it has signed a master franchise agreement in Japan for CycleBar, the world’s largest indoor bike. . The agreement, signed with the Xponential Master Franchisee for the Pilates Club in Japan, gives the Master Franchisee the opportunity to license at least 30 CycleBar studios in Japan over the next 10 years.

Xponential Fitness Signs Master Franchise Agreement in Japan for CycleBar Read More »

Japanese airlines maintain hope throughout the year, helped by demand

TOKYO (Reuters) – ANA Holdings and Japan Airline (JAL) maintained their positive profit outlook for the year on Monday as airlines saw a strong recovery in demand as they grappled with demanding COVID-19 situations and high fuel prices. The virus in Japan has slowed domestic flight bookings, but points such as strong demand for foreign flights continue with a positive outlook, ANA and JAL executives said. quarter,” said Kimihiro Nakahori, ANA Group’s chief financial officer.

Japanese airlines maintain hope throughout the year, helped by demand Read More »

Shionogi Begins Phase Study in Japan on Digital Akili Treatment in Children with ADHD

BOSTON, Aug. 1, 2022–Akili Interactive (“Akili”), a leading virtual medicine company, today announced the initiation of a fundamental, randomized, controlled Phase 3 study of SDT-001 (an edition of AKL-T01 localized for Japanese language and culture), a candidate product designed for care measures in youth diagnosed with attention-deficit/hyperactivity disorder (“ADHD”). The study, conducted by Akili’s partner, the global pharmaceutical company Shionogi

Shionogi Begins Phase Study in Japan on Digital Akili Treatment in Children with ADHD Read More »